Chest ACCP Career Connection
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by BURNETT, P. C.
Right arrow Articles by BRODIE, D.
Right arrow Search for Related Content
PubMed
Right arrow Articles by BURNETT, P. C.
Right arrow Articles by BRODIE, D.
(Chest. 1961;39:403-406.)
© 1961 American College of Chest Physicians

Report on the Use of Cycloserine and Isoniazid in Twenty-seven Cases of Pulmonary Tuberculosis in Psychotic Patients

PAUL C. BURNETT M.D., F.C.C.P. and DONALD BRODIE M.D., F.C.C.P.

Twenty-seven psychotic patients with pulmonary tuberculosis have been treated with cycloserine-isoniazid for periods as long as 26 months. The majority of them had advanced disease of several years' duration and had previously received three standard drug regimens. Some of them had been treated by compression or resectional surgery. Significant improvement was noted in a gratifying percentage of the patients. Reversal of infectiousness occurred in a satisfactory number; roentgenographic improvement was observed in a fair percentage; many showed improvement in well-being and appetite; there was a fairly satisfactory reduction in cough and expectoration. Complicating side effects have been fairly slight, particularly in view of the fact that all of the patients were psychotic. From this clinical experience, it is concluded that a regimen of 500 mgm. of cycloserine and 300 mgm. of isoniazid daily, in two equally divided doses, is a valuable regimen for psychotic patients who still have active disease despite treatment with one of the standard regimens.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1961 by the American College of Chest Physicians.